MaleCare (New York City) presents: Dr. David Agus of Memorial Sloan-Kettering Cancer Center, speaking on "The Failure of Hormone Therapy: Treating Androgen-Dependent and Independent Prostate Cancer."

Dr. Agus is the lead researcher of a study to determine why therapies that block the production of testosterone ultimately fail to prevent a recurrence of prostate cancer. In a separate laboratory study, he researched the effectiveness of a monoclonal antibody called Herceptin and a chemotherapy drug called Taxol.

Wednesday, February 9, at 6 PM, Beth Israel Medical Center 10 Union Square East, between 14th and 15th Street in Manhattan. Second Floor Auditorium.

Free and open to all! Reservations are not needed.

This is the next free monthly meeting of the MaleCare/New York City Prostate Cancer Support Group along with the NYC chapter of US TOO. A talk with slides and your questions!

Join our weekly Tuesday support group for men fighting prostate cancer. Also free and open to all.

MaleCare is the only tri state prostate cancer support program offering free, non partisan, weekly and monthly meetings. Now in our third year, MaleCare is a not for profit for the profit of men's health.

-- Anonymous, February 06, 2000